The latest issues
Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.
All articles
Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States
J Hepatol. 2025;83(1):21-30
The prevalence and rate of undiagnosed celiac disease in an adult general population, the Trøndelag Health Study, Norway
Clin Gastroenterol Hepatol. 2025;23(7):1143-1151
Older adults with celiac disease are at increased risk of frailty: A nationwide cohort study
Am J Gastroenterol. 2025;120(7):1636-1644
Risk of gastric adenocarcinoma after eradication of Helicobacter pylori
Gastroenterology. 2025;169(2):244-250.e1
Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: A multicentre prospective study
Gut. 2025;74(9):1410-1418
Helicobacter pylori antibiotic resistance: A global challenge in search of solutions Background: Helicobacter pylori resistance to antibiotics commonly used in eradication regimens is increasing dramatically in many locations; new strategies are needed to manage this infectious disease.
Gut. 2025;74(10):1561-1570
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): A double-blind, placebo-controlled, randomised, phase 2 trial
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):622-633
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician’s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): A randomised, open-label, phase 2 trial
Lancet. 2025;405(10494):2049-2060
Perioperative durvalumab in gastric and gastroesophageal junction cancer
N Engl J Med. 2025;393(3):217-230